NCT01926847View on ClinicalTrials.gov

Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Raynaud Disease
Interventions
DRUG

Riociguat (Adempas, BAY63-2521)

DRUG

Placebo

Trial Locations (1)

50931

Cologne

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT01926847 - Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator | Biotech Hunter | Biotech Hunter